Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in! Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Emerging Approaches in Schizophrenia
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • View All
Back to top Open menu arrow
Download Free PDF

Save Save

Share Share

Cite Cite

Reprints
Sections
No sections available
Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Access icon
Anxiety Anxiolytics

Letter to the Editor November 10, 2009

Open-Label Trial of Acamprosate as a Treatment for Anxiety

Marc Hertzman, MD ; Ivy S. Patt, PhD ; Lisa A. Spielman, PhD

Prim Care Companion J Clin Psychiatry 2009;11(5):267-267

Article Abstract

Letter to the Editor

Open-Label Trial of Acamprosate as a Treatment for Anxiety

Download Free PDF

This PDF is free for all visitors!

Save Save

Share Share

Cite Cite

Related News Articles

Sports Mount Defense Against Pre-Adolescence Mental Illness Weekly Mind Reader: Cariprazine Shows Promise The Kids Aren’t All Right. Study Says They Need to Get Outside.

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

Adjunctive Cariprazine for Anxiety Symptoms in MDD Defense Mechanisms and Common Psychiatric Disorders Diagnostic Assessment via Telehealth vs Face-to-Face

Related PCC Articles

COVID’s Mental Health Impact on Primary Care Health Workers Childhood Separation Anxiety Disorder and Panic Disorder Mindfulness, Problematic Social Media Use, and Anxiety

Vol 27 • 2025 • Number 2

Read the Current Issue

Original Research

What Internists and Neurologists Know and Think About Catatonia

Original Research

Psychological Morbidities in Hospital Staff During Nipah Virus

Systematic Review

Exercise and Fibromyalgia Pain

Rounds in the General Hospital

Managing Anxiety, Agitation, and Pain in Critically Ill Patients

Review Article

Quality Indicators in Community Mental Health Services: A Scoping Review

Case Report

Is My Patient Diverting Their Lorazepam?

View current Issue

Related Articles

PCC
Letter to the Editor

Resolution of Panic Disorder With Ketamine

July 7, 2016

The antidepressant efficacy of ketamine is clear, but what about its use in other psychiatric disorders? Read about a case of sustained symptom relief following a single ketamine infusion...
Sheena M. Ray , Brent M. Kious
JCP
Letter to the Editor

Correction: Postprandial Oxytocin Secretion Is Associated With Severity of Anxiety and Depressive Symptoms in Anorexia Nervosa

May 27, 2015

PCC
Letter to the Editor

A Case of Hyponatremia Due to Self-Treatment of Anxiety With a Beverage Containing Valerian Root

February 21, 2013

Steven Takeshita , Junji Takeshita

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap